Moreover, FBW7 mutations, region of R465C and R479Q, can also resist GSIs treatment by stabilizing NICD and its principle downstream target c-Myc, which may be the mechanism of GSIs resistance in patients with T-ALL (24). The gene discussed is MYC; the disease is acute lymphoblastic leukemia.